Clinical Trial Update: A Study in Participants With Major Depressive Disorder Who Are Partial Responders to Selective Serotonin Reuptake Inhibitor [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update in patients with major depressive disorder who are partial responders to selective serotonin reuptake inhibitors; results were pos…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Snippet

Sponsor: Eli Lilly and Company | Conditions: Major Depressive Disorder | Phase 3 | Status: COMPLETED | Results posted: 2018-04-27